Acurx Pharmaceuticals ACXP
NASDAQ ACXP
$1.14 +0.00 (+0.44%)
At close: Oct 20, 2026 · 4:00 PM EDT

Acurx Pharmaceuticals (ACXP) EBIT (2024 - 2026)

Updated

Acurx Pharmaceuticals' EBIT was -$2.31 million in Q2 2026, compared with -$2.27 million a year earlier.

Analysis

Acurx Pharmaceuticals (ACXP) EBIT (2024 - 2026) Analysis & Trends

On a trailing twelve-month basis, Acurx Pharmaceuticals' EBIT was -$7.67 million through Jun 30, 2026; for FY2025, it came in at -$8.09 million.

  • In earlier years, EBIT was -$14.12 million in FY2024.
  • The Q2 2026 figure marks the lowest quarterly EBIT since Q4 2024.
  • Per Business Quant data, ACXP's EBIT in the three quarters before Q2 2026 was -$1.72 million (Q1 2026), -$1.62 million (Q4 2025) and -$2.03 million (Q3 2025).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) EBIT (Qtr)
1 Eli Lilly 1,146.94 Bn 1,115.53 Bn 19.71 Bn 11.75 Bn
2 Johnson & Johnson 624.96 Bn 543.49 Bn 17.26 Bn 7.14 Bn
3 AbbVie 510.15 Bn 483.27 Bn 12.70 Bn 6.43 Bn
4 Merck 366.13 Bn 320.51 Bn 12.21 Bn -584.00 Mn
5 Novartis Ag 297.75 Bn 261.74 Bn 11.24 Bn 4.75 Bn
6 Astrazeneca 261.93 Bn 235.62 Bn 12.86 Bn 3.16 Bn
7 Amgen 236.51 Bn 191.91 Bn 7.24 Bn 3.51 Bn
8 Gilead Sciences 194.27 Bn 168.47 Bn 6.22 Bn -10.39 Bn
9 Pfizer 171.74 Bn 118.39 Bn 10.94 Bn 4.27 Bn
10 Acurx Pharmaceuticals 4.92 Mn -28.54 Mn - -2.31 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 -2.31 Mn
Mar 31, 2026 -1.72 Mn
Dec 31, 2025 -1.62 Mn
Sep 30, 2025 -2.03 Mn
Jun 30, 2025 -2.27 Mn
Mar 31, 2025 -2.18 Mn
Dec 31, 2024 -2.79 Mn
Sep 30, 2024 -2.83 Mn
Jun 30, 2024 -4.12 Mn
API Access

Acurx Pharmaceuticals EBIT API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=ebit&ticker=ACXP&period=max&api_key=YOUR_API_KEY